Skip to main content

Author: Bill Snyder

VUMC mourns loss of noted hypertension expert Elijovich

Oct. 28, 2022—Fernando Elijovich, MD, professor of Medicine in the Division of Clinical Pharmacology at Vanderbilt University Medical Center, died in Nashville on Oct. 21. He was 77.

Read more


Translational Research Forum highlights range of studies

Oct. 27, 2022—The 2022 Vanderbilt Translational Research Forum exemplified the range of studies conducted at Vanderbilt University Medical Center that are translating scientific discovery into clinical practice.

Read more


Nominations for Vanderbilt Prize now being accepted

Oct. 27, 2022—Nominations for the 2023 Vanderbilt Prize in Biomedical Science are now being accepted. The nomination deadline is Dec. 1.

Read more


Aging beta cells hasten Type 2 diabetes

Oct. 20, 2022—Vanderbilt investigators have found that aging induces chronic cellular stress in pancreatic beta cells, which could contribute to the development of diabetes as we age.

Read more


Gaudet set to deliver Elam Memorial Lecture Oct. 26

Oct. 13, 2022—Patient-centered health care expert Tracy Gaudet, MD, will deliver the third annual Dr. Roy O. Elam Memorial Lecture Oct. 26 at noon in 214 Light Hall.

Read more


Counting steps can reduce disease risk: study

Oct. 10, 2022—A Vanderbilt study found that using a wearable activity tracker to count and increase the number and intensity of steps taken daily can reduce the risk of several common, chronic diseases.

Read more


Opening a window to glaucoma

Oct. 10, 2022—A metalloprotease enzyme plays an important role in retinal ganglion cell development, Vanderbilt researchers discovered; studying it and other family members may lead to the identification of novel targets for treating glaucoma.

Read more


Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America

Oct. 6, 2022—Vanderbilt's James Crowe Jr., MD, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization.

Read more


VUMC to test whether Alzheimer’s drug can ease lupus symptoms

Oct. 6, 2022—Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer’s drug, memantine, can improve cognitive symptoms associated with systemic lupus.

Read more


Vanderbilt’s Terker wins NIH Director’s Early Independence Award

Oct. 4, 2022—Andrew Terker, MD, PhD, a physician scientist at Vanderbilt University Medical Center who is committed to advancing the understanding and treatment of kidney disease, has received a 2022 National Institutes of Health Director’s Early Independence Award.

Read more


VUMC lands grant to build top-line biosafety facility

Sep. 29, 2022—Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.

Read more


Vanderbilt Translational Research Forum set for Oct. 21

Sep. 29, 2022—Vanderbilt Translational Research Forum, an annual celebration of the “translation” of scientific discovery into clinical practice, will be held Oct. 21 at the Vanderbilt University Student Life Center.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more